Canopy Growth Corporation

CGCNASDAQHealthcare● Active

$1.02

$-0.01(-0.97%)

Market Cap$434352720

P/E Ratio—

52W High$2.38

52W Low$0.844

Avg Volume9.9M

Open$1.04

Beta2.41

Free Cash Flow Financials Revenue

Canopy Growth Corporation (CGC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CGC · free cash flow · updated Jun 8, 2026

Core FCF metrics

CGC · FCF · TTM · margin & CAGR

Free cash flow was −$177.0M for FY2025 (fiscal year ending 2025-03-31), up 38.1% year-over-year The FCF margin was -65.8%.

FY2025 Free Cash Flow−$177.0M▲ +38.1% YoY

Trailing 12M (TTM)−$93.8Mtrailing 4 quarters sum

FCF Margin-65.8%−$177.0M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CGC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$165.8M(11M)−$177.0M▲ +38.1%-65.8%

FY2024−$281.9M(4M)−$285.9M▲ +49.7%-96.2%

FY2023−$557.5M(10M)−$568.0M▲ +4.4%-170.4%

FY2022−$545.8M(48M)−$593.9M▲ +7.2%-124.8%

FY2021−$465.7M(174M)−$639.9M▲ +57.2%-117.0%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CGC · P/FCF · FCF yield · FCF per share

Canopy Growth Corporation (CGC) reported negative free cash flow of −$0.18B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-03-31

Cash flow statement summary

CGC · cash flow statement · operating / investing / financing

For FY2025, Canopy Growth Corporation generated −$165.8M in operating cash flow and spent 11M in capital expenditures, yielding −$177.0M in free cash flow.

Operating Activities

−$165.8M

Cash from core business operations

2025-03-31

Investing Activities

−$47.8M

CapEx, acquisitions & investments

2025-03-31

Financing Activities

+$148.7M

Buybacks, dividends & debt

2025-03-31

FCF FormulaOperating CF (−$165.8M) − |CapEx| (11M) = FCF (−$177.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CGC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Canopy Growth CorporationYOU

CGC

−$177.0M+38.1%-65.8%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Canopy Growth Corporation (CGC) reported free cash flow of −$177.0M for FY2025 (fiscal year ending 2025-03-31), up 38.1% year-over-year. The FCF margin was -65.8%.

Canopy Growth Corporation has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 15 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CGC free cash flow · 8 questions

Canopy Growth Corporation free cash flow was −$177.0M for FY2025, up 38.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$93.8M.

CGC free cash flowCGC FCFCGC FCF 2025CGC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Canopy Growth Corporation · Canopy Growth Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026